Zinc: A promising agent in dietary chemoprevention of cancer

Indian Journal of Medical Research

Volumn 132, Issue 12, 2010, Pages 676-682

  Dhawan, D K ^a   Chadha, Vijayta D ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apoptosis; Cancer; Chemoprevention; Essential elements; Zinc; Zn deficiency

Indexed keywords

CASPASE; MOLECULAR MARKER; PROTEIN P53; ZINC; CASPASE 6;

APOPTOSIS; BIOASSAY; CANCER GROWTH; CHEMOPROPHYLAXIS; CLINICAL RESEARCH; COLON CANCER; DIET SUPPLEMENTATION; ENZYME ACTIVATION; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; NEOPLASM; NONHUMAN; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; ZINC DEFICIENCY; ANIMAL; CARCINOMA; METABOLISM; PHYSIOLOGY; RAT;

ANIMALS; APOPTOSIS; CARCINOMA; CASPASE 6; HUMANS; RATS; TUMOR SUPPRESSOR PROTEIN P53; ZINC;

EID: 78751564086     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Berholf RL. Zinc In: Seiler HG, Sigel H. editors. Handbook on toxicity of inorganic compounds. New York: Dekker; 1988. p. 788-800.
2. Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Pharmacol Rev 1993; 73: 79-118.
3. Vallee BL, Auld DS. Short and long spacer sequences and other structural features of zinc binding sites in zinc enzymes. FEBS Lett 1989; 257: 138-40.
4. Vallee BL, Auld DS. Zinc coordination, function and structure of zinc enzymes and other proteins. Biochemistry 1990; 29: 5647-59.
5. Tapiero H, Tew KD. Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 2003; 57: 399-411.
6. Calesnick B, Dinan AM. Zinc defciency and zinc toxicity. Am Fam Physician 1988; 37: 267-70.
7. Stefanidou SM, Maravelias C, Dona A, Spiliopoulou C. Zinc: a multipurpose trace element. Arch Toxicol 2006; 80: 1-9.
8. Yang BS, Ishii H, Satoh A, Kato N. Supplementation of dietary cysteine elevates kidney metallothionein in rats by a mechanism involving altered zinc metabolism. J Nutr 1995; 125: 1167-74.
9. Robinson HMP, Golden MHN, Golden BE, Simeon DT The zinc sandwich and growth. Lancet 1991; 337: 925-6.
10. Goel A, Dani V, Dhawan DK. Protective potential of Zinc on lipid peroxidation, antioxidant enzymes and hepatic histoarchitecture in chlorpyrifos induced toxicity. Chem Biol Int 2005; 156: 131-40.
11. Goel A, Dani V, Dhawan DK. Chlorpyrifos-induced alterations in the activities of carbohydrate metabolizing enzymes in rat liver: The role of zinc. Toxicol Lett 2006; 163: 235-41.
12. Bandhu HK, Dani V, Garg ML, Dhawan DK. Hepatoprotective role of zinc in lead treated protein defcient rats. Drug Chem Toxicol 2006; 1: 11-24.
13. Chadha VD, Bhalla P, Dhawan DK. Zinc modulates lithium induced hepatotoxicity in rats. Liver Int 2008; 28: 558-65.
14. 131I induced changes on the antioxidant system and morphology of red blood cells of rat. Hell J Nucl Med 2006; 9: 22-6.
15. 4 induced oxidative stress in rat liver. Toxicol Mech Method 2006; 16: 37-40.
16. Ho E. Zinc defciency, DNA damage and cancer risk. J Nutr Biochem 2004; 15: 572-8.
17. Ho E, Courtemanche C, Ames BN. Zinc defciency induces oxidative DNA damage and increases p53 expression in human lung fbroblasts. J Nutr 2003; 133: 2543-8.
18. Witkiewicz-Kucharczyk A, Bal W. Damage of zinc fngers in DNA repair proteins, a novel molecular mechanism in carcinogenesis. Toxicol Lett 2006; 162: 29-42.
19. Dong J, Park JS, Lee SH. In vitro analysis of the zinc-fnger motif in human replication protein A. Biochem J 1999; 337: 311-7.
20. Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 1993; 7: 2556-4.
21. Ho E, Ames BN. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFkappa B, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 2002; 99: 16770-5.
22. Singh KP, Zaidi SIA, Raisuddin S, Saxena AK, Murthy RC, Ray PK. Effect of zinc on immune functions and host resistance against infection and tumor challenge. Immunopharmacol Immunotoxicol 1992; 14: 813-40.
23. Satoh M, Kondo Y, Mita M, Nakagawa I, Naganuma A, Imura N. Prevention of carcinogenecity of anticancer drugs by metallothionein induction. Cancer Res 1993; 53: 4767-8.
24. Dani V, Goel A, Vaiphei K, Dhawan DK. Chemopreventive potential of zinc in experimentally induced colon carcinogenesis. Toxicol Lett 2007; 171: 10-8.
25. Dani V, Vaiphei K, Dhawan DK. Zinc mediated normalization of histoarchitecture and antioxidant status offers protection against initiation of experimental carcinogenesis. Mol Cell Biochem 2007; 27: 595-607.
26. Dani V, Dhawan DK. Membrane fuidity and surface changes during initiation of 1,2 dimethylhydrazine induced colon carcinogenesis: Protection by Zinc. Oncol Res 2009; 18: 17-23.
27. Schrauzer GN. Trace elements in carcinogenesis. In: Draper HH, editor. Advances in nutritional research, vol.II. New York: Plenum; 1979. p. 219-44.
28. Fong LYY, Sivak A, Newberne PM. Zinc defciency and methylbenzylnitrosamine induced esophageal cancer in rats. J Natl Cancer Inst 1978; 61: 145-50.
29. Zowezak M, Iskra M, Torlinski L, Cofta S. Analysis of copper and zinc concentrations in cancer patients. Biol Trace Elem Res 2001; 82: 1-8.
30. Fong LY, Nguyen VT, Farber JL. Esophageal cancer prevention in zinc defcient rats: Rapid induction of apoptosis by replenishing zinc. J Natl Cancer Inst 2001; 93: 1525-33.
31. Fong LY, Farber JL, Magee PN. Zinc replenishment reduces esophageal cell proliferation and N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumor incidence in zinc-defcient rats. Carcinogenesis 1998; 19: 1591-6.
32. Siglin JC, Khare L, Stoner GD. Evaluation of dose and treatment duration on the esophageal tumorigenicity of N-nitrosomethylbenzylamine in rats. Carcinogenesis 1995; 16: 259-65.
33. Abnet CC, Lai B, Qiao YL, Vogt S, Luo xM, Taylor PR, et al. Zinc concentration in esophageal biopsy specimens measured by X-ray fuorescence and esophageal cancer risk. J Natl Cancer Inst 2005; 97: 301-6.
34. Boehm T, O'Reilly MS, Keough K, Shiloach J, Shapiro R, Folkman J. Zinc binding of endostatin is essential for its antiangiogenic activity. Biochem Biophys Res Commun 1998; 252: 190-4.
35. Jaiswal AS, Narayan S. Zinc stabilizes adenomatous polyposis coli (APC) protein levels and induces cell cycle arrest in colon cancer cells. J Cell Biochem 2004; 93: 345-57.
36. Costello LC, Feng P, Milon B, Tan M, Franklin RB. Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 2004; 7: 111-7.
37. Gallus S, Foschi R, Negri E, Talamini R, Franceschi S, Montella M, et al. Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol 2007; 52: 1052-6.
38. Ho E, Yang S. Zinc and prostatic cancer. Curr Opin Clin Nutr Metab Care 2009; 12: 640-5.
39. Yan M, Song Y, Wong CP, Hardin K, Ho E. Zinc defciency alters DNA damage response genes in normal human prostate epithelial cells. J Nutr 2008; 138: 667-73.
40. Franklin RB, Milon B, Feng P, Costello LC. Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer. Front Biosci 2005; 10: 2230-9.
41. Kane DJ, Sarafan TA, Anton R, Hahn H, Gralla EB, Valentine JS, et al. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science 1993; 262: 1274-7.
42. Sandstrom PA, Mannie MD, Buttke TM. Inhibition of activation induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis. J Leukoc Biol 1994; 55: 221-6.
43. Lindahl M, Leanderson P, Tagesson C. Novel aspects on metal fume fever: Zinc stimulates oxygen radical formation in human neutrophils. Hum Exp Toxicol 1998; 17: 105-10.
44. Noh KM, Koh JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurochem 2000; 75: 1878-88.
45. Truong-Tran AQ, Ho LH, Chai F, Zalewski PD. Cellular zinc fuxes and the regulation of apoptosis/Gene directed cell death. J Nutr 2000; 130: 1459-66.
46. Beyersmann D. Homeostasis and cellular functions of zinc. Mat Wiss U Werkstofftech 2002; 33: 764-9.
47. Nath R, Kumar D, Li T, Singal P K. Metallothioneins, oxidative stress and the cardiovascular system. Toxicology 2000; 155: 17-26.
48. th ed. Philadelphia: Saunders, An Imprint of Elsevier; 2003.
49. Dreosti IE. Zinc and the gene. Mutat Res 2001; 475: 161-7.
50. Verhaegh GW, Parat MO, Richard MJ, Hainaut P. Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. Mol Carcinog 1998; 21: 205-14.
51. Palecek E, Brazdova M, Cernocka H, Vlk D, Brazda V, Vojtesek B. Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments. Oncogene 1999; 18: 3617-25.
52. Cho Y, Gorina S, Jafferey PD, Pavletich NP. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumrogenic mutations. Science 1994; 265: 346-55.
53. Meplan C, Richard MJ, Hainault P. Metalloregulation of the tumor suppressor protein p53: Zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 2000; 19: 5227-36.
54. 2+ -induced apoptosis in cancer cells. Free Radic Biol Med 2002; 32: 431-45.
55. Seve M, Chimienti F, Favier A. Role of intracellular zinc in programmed cell death. Pathol Biol 2002; 50: 212-21.
56. Mocchegiani E, Giacconi R, Cipriano C, Gasparini N, Orlando F, Stecconi R, et al. Metallothioneins (I+II) and thyroid-thymus axis effciency in old mice: role of corticosterone and zinc supply. Mech Ageing Dev 2002; 123: 675-94.
57. Mocchegiani E, Santarelli L, Tibaldi A, Muzzioli M, Bulian D, Cipriano K, et al. Presence of links between zinc and melatonin during the circadian cycle in old mice: effects on thymic endocrine activity and on the survival. J Neuroimmunol 1998; 86: 111-22.
58. Liang JY, Liu YY, Zou J, Franklin RB, Costello LC, Feng P. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 1999; 40: 200-7.
59. Mocchegiani E, Ciavattini A, Santarelli L, Tibaldi A, Muzzioli M, Bonazzi P, et al. Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune effciency (natural killer activity and interleukin 2) in cervical carcinoma. Br J Cancer 1999; 79: 244-50.
60. McCabe MJ, Jiang SA, Orrenius S. Chelation of intracellular zinc triggers apoptosis in mature thymocytes. Lab Invest 1993; 69: 101-10.
61. Hasse P, Cowen DM, Knowles JC, Cooper EH. Evaluation of dimethylhydrazine induced tumors in mice as a model system for colorectal cancer. Br J Cancer 1973; 28: 530-43.
62. Lee DH, Anderson KE, Harnack LJ, Folsom AR, Jacobs DR. Heme, iron, zinc, alcohol consumption, and colon cancer: Iowa women's health study. J Natl Cancer Inst 2004; 96: 403-7.
63. Prasad AS, Beck FWJ, Doerr TD, Shamsa FH, Penny HS, Marks SC, et al. Nutritional and zinc status of head and neck cancer patients: An interpretive review. J Am College Nutr 1998; 17: 409-18.
64. Abdulla M, Biorklund A, Mathur A, Wallenius K. Zinc and copper levels in whole blood and plasma from patients with squamous cell carcinomas of head and neck. J Surg Oncol 1979; 12: 107-13.
65. Costello LC, Franklin RB, Feng P, Tan M, Bagasra O. Zinc and prostate cancer: a critical scientifc, medical, and public interest issue (United States). Cancer Causes Control 2005; 16: 901-15.